ENPP3
ENPP3 (ectonucleotide pyrophosphatase/phosphodiesterase 3, also known as CD203c, PD-IBETA, gp130RB13-6, B10 and PDNP3) is a type II transmembrane ectoenzyme that hydrolyses extracellular nucleotides. It limits nucleotide signalling in inflammation and regulates innate immune responses. Browse Assay Genie's current range of ENPP3 research reagents below, or read on for the biology behind the target.
ENPP3 is a hydrolase that metabolises extracellular nucleotides, including ATP, GTP, UTP and CTP. It also hydrolyses extracellular 2',3'-cGAMP, a second messenger that activates TMEM173/STING and triggers type-I interferon production, so it contributes to regulation of the innate immune response. 2',3'-cGAMP appears to be processed further to GMP, AMP and inorganic phosphate. By removing extracellular ATP, ENPP3 limits mast cell and basophil responses during inflammation and the chronic phases of allergic responses, since ATP activates these cells in an autocrine manner. In the lumen of the small intestine it also prevents ATP-induced apoptosis of intestinal plasmacytoid dendritic cells.
The enzyme has broad specificity. It can hydrolyse UDP-GlcNAc into UMP and GlcNAc-1-phosphate, and potentially other nucleotide sugars such as UDP-GalNAc, CMP-NeuAc, GDP-Fuc and UDP-GlcA, so it could modulate glycan biosynthesis and protein glycosylation. It also acts on extracellular dinucleoside polyphosphates, including vasoactive adenosine polyphosphates, and shows alkaline phosphodiesterase activity in vitro. The ENPP3 protein localises to the cell membrane, including the apical membrane, and is also found in a secreted form.
The ENPP3 gene encodes a member of the nucleotide pyrophosphatase/phosphodiesterase family, listed by HGNC in the CD molecules group as CD203c. These type II transmembrane ectoenzymes have ATPase and ATP pyrophosphatase activities. Human ENPP3 mRNA is expressed in glioma cells, prostate and uterus, and the protein has been detected in uterus, basophils and mast cells. Two transcript variants are known, one protein coding and one non-protein coding. Mouse and rat orthologs are both named Enpp3.
ENPP3 removes extracellular ATP that activates mast cells and basophils, limiting their response during inflammation and chronic allergic reactions.
By hydrolysing extracellular 2',3'-cGAMP, ENPP3 influences TMEM173/STING activation and type-I interferon production.
ENPP3 metabolises ATP, GTP, UTP, CTP and dinucleoside polyphosphates, making it a useful enzyme for studying extracellular nucleotide turnover.
ENPP3 can hydrolyse nucleotide sugars and clears luminal ATP in the small intestine, protecting plasmacytoid dendritic cells from apoptosis.
ENPP3 hydrolyses extracellular nucleotides such as ATP, GTP, UTP and CTP, as well as 2',3'-cGAMP and dinucleoside polyphosphates. By clearing extracellular ATP it dampens mast cell and basophil activation and protects intestinal plasmacytoid dendritic cells from ATP-induced apoptosis.
ENPP3 is also known as CD203c, PD-IBETA, gp130RB13-6, B10 and PDNP3. The HGNC name is ectonucleotide pyrophosphatase/phosphodiesterase 3. The gene produces two transcript variants, one protein coding and one non-protein coding.
Yes. Mouse and rat both have an Enpp3 ortholog. Rat Enpp3 mRNA has been found in immature glial cells and the alimentary tract, and the rat protein in pancreas, small intestine, colon and liver. Check the datasheet of any product for its validated reactivity.
Other ectonucleotide pyrophosphatase/phosphodiesterase family members involved in extracellular nucleotide metabolism.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O14638; product specifications from Assay Genie datasheets.